Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ryo, Ito"'
Autor:
Hikaru Ueno, Ryo Ito, Shin-Ichi Abe, Hitomi Ogino, Minoru Maruyama, Hirohisa Miyashita, Yasufumi Miyamoto, Yusuke Moritoh, Yoshiyuki Tsujihata, Koji Takeuchi, Nobuhiro Nishigaki
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222653 (2019)
GPR40/FFAR1 is a Gq protein-coupled receptor expressed in pancreatic β cells and enteroendocrine cells, and mediates insulin and incretin secretion to regulate feeding behavior. Several GPR40 full agonists have been reported to reduce food intake in
Externí odkaz:
https://doaj.org/article/8b8c641e5d7b42ad9c100d8692af4d44
Autor:
Dai Suzuki, Akiko Saito-Hakoda, Ryo Ito, Kyoko Shimizu, Rehana Parvin, Hiroki Shimada, Erika Noro, Susumu Suzuki, Ikuma Fujiwara, Hiroyuki Kagechika, William E Rainey, Shigeo Kure, Sadayoshi Ito, Atsushi Yokoyama, Akira Sugawara
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0181055 (2017)
The effects of retinoids on adrenal aldosterone synthase gene (CYP11B2) expression and aldosterone secretion are still unknown. We therefore examined the effects of nuclear retinoid X receptor (RXR) pan-agonist PA024 on CYP11B2 expression, aldosteron
Externí odkaz:
https://doaj.org/article/1b3a8c55203c4caa987da0dc38cf938b
Autor:
Chiori Yabuki, Hidetoshi Komatsu, Yoshiyuki Tsujihata, Risa Maeda, Ryo Ito, Kae Matsuda-Nagasumi, Kensuke Sakuma, Kazumasa Miyawaki, Naoya Kikuchi, Koji Takeuchi, Yugo Habata, Masaaki Mori
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e76280 (2013)
Selective free fatty acid receptor 1 (FFAR1)/GPR40 agonist fasiglifam (TAK-875), an antidiabetic drug under phase 3 development, potentiates insulin secretion in a glucose-dependent manner by activating FFAR1 expressed in pancreatic β cells. Althoug
Externí odkaz:
https://doaj.org/article/875ecff2c84d4653af7caf3a7d844768
Autor:
Nobuhiro Nishigaki, Hikaru Ueno, Yasufumi Miyamoto, Hirohisa Miyashita, Koji Takeuchi, Yoshiyuki Tsujihata, Minoru Maruyama, Ryo Ito, Hitomi Ogino, Yusuke Moritoh, Shin-ichi Abe
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222653 (2019)
PLoS ONE
PLoS ONE
GPR40/FFAR1 is a Gq protein-coupled receptor expressed in pancreatic β cells and enteroendocrine cells, and mediates insulin and incretin secretion to regulate feeding behavior. Several GPR40 full agonists have been reported to reduce food intake in
Autor:
Susumu Suzuki, Shigeo Kure, Hiroyuki Kagechika, Dai Suzuki, Akiko Saito-Hakoda, Sadayoshi Ito, William E. Rainey, Ikuma Fujiwara, Rehana Parvin, Atsushi Yokoyama, Akira Sugawara, Kyoko Shimizu, Hiroki Shimada, Erika Noro, Ryo Ito
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0181055 (2017)
PLoS ONE
PLoS ONE
The effects of retinoids on adrenal aldosterone synthase gene (CYP11B2) expression and aldosterone secretion are still unknown. We therefore examined the effects of nuclear retinoid X receptor (RXR) pan-agonist PA024 on CYP11B2 expression, aldosteron
Autor:
Kazumasa Miyawaki, Kae Matsuda-Nagasumi, Koji Takeuchi, Yugo Habata, Hidetoshi Komatsu, Chiori Yabuki, Risa Maeda, Naoya Kikuchi, Kensuke Sakuma, Yoshiyuki Tsujihata, Masaaki Mori, Ryo Ito
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e76280 (2013)
PLoS ONE
PLoS ONE
Selective free fatty acid receptor 1 (FFAR1)/GPR40 agonist fasiglifam (TAK-875), an antidiabetic drug under phase 3 development, potentiates insulin secretion in a glucose-dependent manner by activating FFAR1 expressed in pancreatic β cells. Althoug